A Paradigm Shift from Research to Front-Line Microbial Diagnostics in MALDI-TOF and LC-MS/MS / Criteria for Development of MALDI-TOF Mass Spectral Database / Applications of MALDI-TOF Mass Spectrometry in Clinical Diagnostic Microbiology / The Challenges of Identifying Mycobacterium to the Species Level using MALDI-TOF MS / Transformation of Anaerobic Microbiology since the Arrival of MALDI-TOF Mass Spectrometry / Differentiation of Closely Related Organisms using MALDI-TOF MS / Identification of Species in Mixed Microbial Populations using MALDI-TOF MS / Microbial DNA Analysis by MALDI-TOF Mass Spectrometry / Impact of MALDI-TOF MS in Clinical Mycology : Progress and Barriers in Diagnostics / Development and Application of MALDI-TOF for Detection of Resistance Mechanisms / Discrimination of Burkholderia Species, Brucella Biovars, Francisella tularensis and Other Taxa at the Subspecies Level by MALDI-TOF Mass Spectrometry / MALDI-TOF-MS Based on Ribosomal Protein Coding in S10-spc-alpha Operons for Proteotyping / Tandem Mass Spectrometry Analysis as an Approach to Delineate Genetically Related Taxa / Mapping of the Proteogenome of Clostridium difficile Isolates of Varying Virulence / Determination of Antimicrobial Resistance using Tandem Mass Spectrometry / Proteotyping / Proteogenomics of Pseudomonas aeruginosa in Cystic Fibrosis Infections / Top-Down Proteomics in the Study of Microbial Pathogenicity / Tandem Mass Spectrometry in Resolving Complex Gut Microbiota Functions / Proteogenomics of Non-model Microorganisms / Analysis of MALDI-TOF MS Spectra using the BioNumerics Software / Subtyping of Staphylococcus spp. Based upon MALDI-TOF MS Data Analysis / Elucidating the Intra-Species Proteotypes of Pseudomonas aeruginosa from Cystic Fibrosis